v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 13 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Operating activities:              
Net loss $ (2,892) $ (3,046) $ (2,250) $ (1,887) $ (5,938) $ (4,137)  
Adjustments to reconcile net loss to cash used in operating activities:              
Depreciation expense 1   1   2 2  
Stock-based compensation expense         261 74  
Change in fair value of warrant liability         0 (3)  
Change in operating lease right-of-use assets         23    
Change in operating lease right-of-use assets           (127)  
Change in operating assets and liabilities:              
Prepaid expenses and other current assets         133 370  
Accounts payable         371 (400)  
Accrued expenses         269 (250)  
Operating lease liabilities         (23) 127  
Cash used in operating activities         (4,902) (4,344)  
Financing activities:              
Payment for fractional shares in connection with reverse stock split         (1) 0  
Payment of stock issuance costs         (944) (1,571)  
Cash provided by financing activities         4,996 8,889  
Net increase in cash and cash equivalents         94 4,545  
Cash and cash equivalents at beginning of period   $ 5,028   $ 1,808 5,028 1,808  
Cash and cash equivalents at end of period 5,122   $ 6,353   5,122 6,353 $ 5,122
Supplemental disclosure of non-cash financing activities:              
Deferred stock issuance costs in accounts payable and accrued expenses         29 367  
Issuance of warrants for payment of stock issuance costs         123 0  
Through Financing              
Financing activities:              
Proceeds from issuance of common stock         5,000 9,499  
ATM              
Financing activities:              
Proceeds from issuance of common stock $ 941       $ 941 $ 961 $ 4,546